Multiple Myeloma Hub’s Post

Watch Sagar Lonial’s presentation from our latest symposium on the current and future perspectives for bispecific antibodies in #MultipleMyeloma. Key points covered in this presentation include: ▪️ The increasing options for patients with relapsed/refractory multiple myeloma ▪️ The mechanism of action of BsAbs works by binding to CD3 and a plasma cell target ▪️ BsAbs bring T-cells in close proximity to malignant tumor cells, resulting in #myeloma cell death ▪️ Rational targets include BCMA, GPRC5D, and FcRH5 https://loom.ly/P-xfbwg #mmsm

Check out my interview with "The Onc Doc": Sanjay Juneja, M.D. on his podcast "Target Cancer." We discuss how the SAGE Oncotest can guide you and your oncologist to identify the best treatment for your very unique cancer.

We are thrilled to share a recording of a GlycoNet webinar featuring Dr. Paula Videira, Co-Founder of CellmAbs, Co-director of GLYCOTwinning, and Associate Professor at Faculdade de Ciências e Tecnologia da Universidade NOVA de Lisboa. Introduced by Mr. David Firer, Chair of the GlycoNet Trainee Association – Executive Committee, Dr. Videira dives deep into "Unlocking the Glycoimmune Potential: Novel Strategies for Advanced Immunotherapy". Additionally, don’t miss the insightful presentation by her PhD student, Ms. Rita Adubeiro Lourenço, on "Deciphering the Enigmatic Role of O-glycan Signatures in Cancer". 👉 Watch the full recording here: https://lnkd.in/drFNUuS2 Learn more about GlycoNet and GLYCOTwinning and join us in advancing the field of glycomics and immunotherapy. #GlycoNet #GLYCOTwinning #Glycomics #glycobiology #CancerResearch #Glycoscience #Webinar

Don't miss our interview with Sanjay Juneja, M.D. We're covering several important topics: 1. How to catch cancer much earlier to "live long and prosper!" 2. Why current diagnostics, including genomic testing, fall short of finding the best therapy for you. 3. How the SAGE Oncotest can help you to receive the most effective treatment. https://lnkd.in/g9AAuH8v

In this video, Dr. Brian Sworder discusses the objective, methodology, and key results for one of the studies presented at the American Society of Hematology (#ASH) Annual Conference in 2023. The study shows the #utility of our proprietary technology, PhasED-Seq™ #MRD, vs. PET/CT to predict response following #curative intent induction #therapy in patients with diffuse large B-cell lymphoma (#DLBCL). #ForesightDx's ultra-sensitive liquid biopsy platform, Foresight CLARITY™ , is powered by PhasED-Seq™. Watch video here: https://t.ly/tyKgX Learn more about Foresight CLARITY here: https://t.ly/UnwGW #ForesightCLARITY #PhasEDseq #ctDNA #MRD #PrecisionMedicine #LiquidBiopsy

Lung nodules - not an uncommon source of angst amongst doctors & patients as one always wonders if it’s benign or malignant. The article highlights how common it is in Western Europe. I reckon it might be more common in Asia, given the highest prevalence of infections as well as nodule-mimics like granulomas. Something to consider as we advocate for more low-dose CT scans to screen for lung cancer. In the absence of blood tests and other biomarkers, there isn’t much more than can be done besides to watch and wait - if it’s of a small size, CT scans over a period of time help ascertain if further intervention is warranted. https://lnkd.in/g6yneMTa

🎥 Join us for this insightful interview with Dr. Ángel R. Nebreda, a leading scientist dedicated to cancer research, ICREA Professor and Group Leader of the Signalling and Cell Cycle Laboratory at IRB Barcelona👇 ✅ Discover how his research laboratory deciphers the ways in which cells interpret external signals to regulate their growth, differentiation, and survival, particularly within tumors. Learn about the pivotal role of the stress-activated p38 MAPK pathway in these processes. ✅ Dr. Nebreda's groundbreaking work has revealed how p38 MAPKs integrate signals, maintain homeostasis, and impact cancer development and progression. Watch the interview here ▶ https://lnkd.in/etcQ4H88 Institució Catalana de Recerca i Estudis Avançats, ICREA ICERCA - Centres de Recerca de Catalunya Barcelona Institute of Science and Technology (BIST) SOMM Alliance Parc Científic de Barcelona #MeetOurScientists #Biomedicine #BreastCancer #Cancer #CancerBiology #CancerResearch #CellSignaling #Chemotherapy #Interview #p38MAPK #Research

🎥 Join us for this insightful interview with Dr. Ángel R. Nebreda, a leading scientist dedicated to cancer research, ICREA Professor and Group Leader of the Signalling and Cell Cycle Laboratory at IRB Barcelona👇 ✅ Discover how his research laboratory deciphers the ways in which cells interpret external signals to regulate their growth, differentiation, and survival, particularly within tumors. Learn about the pivotal role of the stress-activated p38 MAPK pathway in these processes. ✅ Dr. Nebreda's groundbreaking work has revealed how p38 MAPKs integrate signals, maintain homeostasis, and impact cancer development and progression. Watch the interview here ▶ https://lnkd.in/etcQ4H88 Institució Catalana de Recerca i Estudis Avançats, ICREA ICERCA - Centres de Recerca de Catalunya Barcelona Institute of Science and Technology (BIST) SOMM Alliance Parc Científic de Barcelona #MeetOurScientists #Biomedicine #BreastCancer #Cancer #CancerBiology #CancerResearch #CellSignaling #Chemotherapy #Interview #p38MAPK #Research https://lnkd.in/etcQ4H88

Try AgeLOC Cordyceps https://lnkd.in/g3h2DBW (Not ADD Pitch-FYI) https://lnkd.in/dXi5ZFWq 6 Benefits of Cordyceps, All Backed by Science

Check out our upcoming webinar that focuses on a matched pair of immortalized primary preadipocytes that are anticipated to be a critical resource for physiological, pharmacological, and genetic studies of metabolic diseases.